Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-β1 in cultured cardiac fibroblasts

被引：39
作者：
Shyu, Kou-Gi [2 ,3 ]
Wang, Bao-Wei [2 ,4 ]
Chen, Wei-Jan [5 ]
Kuan, Peiliang [2 ]
Hung, Chi-Ren [1 ]
机构：
[1] Shin Kong Wu Ho Su Mem Hosp, Div Cardiovasc Surg, Taipei, Taiwan
[2] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan
[3] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[4] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan
[5] Chang Gung Mem Hosp, Cardiovasc Div 1, Linkou, Taipei County, Taiwan
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2010年 / 12卷 / 03期
关键词：
Fibroblast; Endoglin; Fibrosis; Statin; Transforming growth factor-beta 1; GROWTH-FACTOR-BETA; NITRIC-OXIDE SYNTHASE; REDUCTASE INHIBITOR; COLLAGEN-SYNTHESIS; UP-REGULATION; FIBROSIS; HYPERTROPHY; PITAVASTATIN; FLUVASTATIN; INDUCTION;
D O I：
10.1093/eurjhf/hfq011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Transforming growth factor-beta 1 (TGF-beta 1) and endoglin play a causal role in promoting cardiac fibrosis. Atorvastatin has been shown to have an inhibitory effect on cardiac fibroblasts in vitro. However, the effects of statins on TGF-beta 1 and endoglin are poorly understood. We therefore sought to investigate the molecular mechanisms of atorvastatin on endoglin expression after TGF-beta 1 stimulation in cardiac fibroblasts. Cultured cardiac fibroblasts were obtained from adult male Sprague-Dawley rat hearts. TGF-beta 1 stimulation increased endoglin and collagen I expression and atorvastatin inhibited the induction of endoglin and collagen I by TGF-beta 1. Phosphatidylinositol-3 kinase (PI-3) and Akt inhibitors (wortmannin and Akt inhibitor X) completely attenuated the endoglin protein expression induced by TGF-beta 1. TGF-beta 1 induced phosphorylation of PI-3 kinase and Akt, while atorvastatin and wortmannin and Akt inhibitor X inhibited the phosphorylation of PI-3 kinase and Akt induced by TGF-beta 1. The gel shift and promoter activity assay showed that TGF-beta 1 increased Smad3/4-binding activity and endoglin promoter activity, while wortmannin and atorvastatin inhibited the Smad3/4-binding activity and endoglin promoter activity induced by TGF-beta 1. TGF-beta 1 increased collagen I protein expression, while endoglin siRNA attenuated collagen I protein expression induced by TGF-beta 1. Atorvastatin decreased left ventricular TGF-beta 1, endoglin, and collagen I protein expression and fibrotic area in a rat model of volume overload heart failure. Atorvastatin inhibits endoglin expression through the inhibition of PI-3 kinase, Akt, and Smad3 phosphorylation, and reduced Smad3/4 binding activity and endoglin promoter activity in cardiac fibroblasts.
引用
收藏
页码：219 / 226
页数：8
相关论文
共 32 条
  • [11] Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
    Horwich, TB
    MacLellan, WR
    Fonarow, GC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 642 - 648
  • [12] Effect of high-dose atorvastatin on hospitalizations for heart failure - Subgroup analysis of the treating to new targets (TNT) study
    Khush, Kiran K.
    Waters, David D.
    Bittner, Vera
    Deedwania, Prakash C.
    Kastelein, John J. P.
    Lewis, Sandra J.
    Wenger, Nanette K.
    [J]. CIRCULATION, 2007, 115 (05) : 576 - 583
  • [13] Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats
    Kuwahara, F
    Kai, H
    Tokuda, K
    Kai, M
    Takeshita, A
    Egashira, K
    Imaizumi, T
    [J]. CIRCULATION, 2002, 106 (01) : 130 - 135
  • [14] Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    Laufs, U
    La Fata, V
    Plutzky, J
    Liao, JK
    [J]. CIRCULATION, 1998, 97 (12) : 1129 - 1135
  • [15] Induction of cardiac fibrosis by transforming growth factor-β1
    Lijnen, PJ
    Petrov, VV
    Fagard, RH
    [J]. MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) : 418 - 435
  • [16] Role of transforming growth factor-β in the progression of heart failure
    Lim, H.
    Zhu, Y. Z.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (22) : 2584 - 2596
  • [17] CAMP inhibits transforming growth factor-β-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts
    Liu, Xiaoqiu
    Sun, Shu Qiang
    Hassid, Aviv
    Ostrom, Rennolds S.
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (06) : 1992 - 2003
  • [18] In vitro inhibitory effects of atorvastatin on cardiac fibroblasts:: Implications for ventricular remodelling
    Martin, J
    Denver, R
    Bailey, M
    Krum, H
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (09) : 697 - 701
  • [19] Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment
    Nachtigal, Petr
    Pospisilova, Nada
    Jamborova, Gabriela
    Pospechova, Katerina
    Solichova, Dagmar
    Andrys, Ctirad
    Zdansky, Petr
    Semecky, Vladimir
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 85 (08) : 767 - 773
  • [20] Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells
    Oi, S
    Haneda, T
    Osaki, J
    Kashiwagi, Y
    Nakamura, Y
    Kawabe, J
    Kikuchi, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) : 139 - 148
1234